| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441740 | European Journal of Cancer | 2015 | 10 Pages |
Abstract
Adjuvant or neo-adjuvant treatment in FDCS and HS did not affect OS. Patients with IDCS had an excellent outcome with surgery. In the metastatic setting, chemotherapy and small molecule inhibitors may provide benefit.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mrinal Gounder, Ved Desai, Deborah Kuk, Narasimhan Agaram, Maria Arcila, Benjamin Durham, Mary L. Keohan, Mark A. Dickson, Sandra P. D'Angelo, Neerav Shukla, Craig Moskowitz, Ariela Noy, Robert G. Maki, Diego Adrianzen Herrera, Armando Sanchez,